This hypothesis is particularly strong for schizophrenia since administration of NMDAR channel blockers in humans replicates the symptoms in schizophrenia1, 2, 3 and agonists for the GluN1 subunit glycine, D-serine and D-cycloserine partly alleviate schizophrenia symptoms4, 5. Here, GRIN1 is linked to schizophrenia.